⌕
Virtus Biotech Clinical Trials ETF · BBC · NYSE Arca
A sector position · not Tenet-scored
Compare
$42.53−1.42%At close
$42.53−0.61 (−1.42%)
At close: Nov 13, 2026, 4:00 PM ET· NYSE Arca · USD

Virtus Biotech Clinical Trials ETF (BBC) Price

Sources Fund holdings disclosures and market prices Fund disclosures and pricesPrice as of How we compute thisNot investment advice

Price

Loading chart…

Price return, distributions not included.

Snapshot

Sector Equity · HealthcareIssuer: VirtusNAV $45.15 (Nov 11)
Expense ratio
0.65%
annual fee
Assets
$31.6M
as of Nov 11, 2026
Holdings
198
positions declared
Distribution yield (TTM)
1.5%
as of Nov 13, 2026
Inception
2014
launch year

We can list 130 of the 198 holdings our data provider declares for this fund. Its own count is 68 above the file it sent.

THE VERDICT

A sector position. At a 0.65% fee and 1.5% distribution yield, the fee eats into returns over time. Its largest tilt is Healthcare (~100%).

This label comes from the fund's own properties: what it holds, its category, asset class, expense ratio, yield, leverage and whether it pays regular income. Nothing about the reader enters it, and it is not the Tenet Score.

At a glance

the case for and against

Why own it

▲Well spread across 130 of ~198 holdings, no single-name reliance.
▲Long track record since 2014, through multiple cycles.

Watch out for

▼Concentrated tilt: Healthcare make up ~100% of the basket.
▼Higher cost. A 0.65% expense ratio eats into returns over time.

Best suited for

Investors who want targeted exposure to one industry or theme and accept that it can move very differently from the broad market.

Basket · as of Nov 13, 2026

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.